{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:49:05Z","timestamp":1789386545142,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6_suppl_4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2004,3,23]]},"DOI":"10.1212\/wnl.62.6_suppl_4.s18","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:22:52Z","timestamp":1336918972000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Apomorphine"],"prefix":"10.1212","volume":"62","author":[{"given":"Mark","family":"Stacy","sequence":"first","affiliation":[{"name":"From the Movement Disorders Program, Duke University, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.6.681"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110607"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.5.573"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10281"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.5571"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.2.369"},{"key":"e_1_3_2_8_2","first-page":"S101.","volume":"17","year":"2002","unstructured":"Bottini P, Shaw A, Huang M-Y, Sherry JH. Apomorphine pharmacokinetic-pharmacodynamic correlations following single and repeated subcutaneous injections in patients with Parkinson\u2019s disease. Mov Disord. 2002; 17 (suppl 5); S101. Abstract.","journal-title":"Mov Disord"},{"key":"e_1_3_2_9_2","first-page":"R6219.","volume":"4","year":"2002","unstructured":"Liao S, Liu M, Shaw A, Huang M. Population pharmacokinetic\/pharmacodynamic models for motor response of apomorphine in patients with idiopathic Parkinson\u2019s disease. AAPS Pharm Sci. 2002; 4: R6219.","journal-title":"AAPS Pharm Sci"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.9.1385"},{"key":"e_1_3_2_11_2","unstructured":"Data on file Mylan Pharmaceuticals."},{"key":"e_1_3_2_12_2","first-page":"A81.","volume":"60","year":"2003","unstructured":"Sherry JH, Guyton PJ, van Lunen B, Bottini PB. Continued efficacy and safety of subcutaneous injections of apomorphine in the treatment of off episodes in patients with Parkinson\u2019s disease. Neurology. 2003; 60 (suppl 1): A81.","journal-title":"Neurology"},{"key":"e_1_3_2_13_2","unstructured":"Sherry JH. Mylan Pharmaceuticals. Personal communication."},{"key":"e_1_3_2_14_2","unstructured":"Data on file Mylan Pharmaceuticals February 2003."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100038518"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.2.458"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199619010-00004"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.247"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200002)47:2<141::AID-ANA1>3.0.CO;2-6"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.86.1.249"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1060937"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200110000-00003"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.62.6_suppl_4.S18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:10:51Z","timestamp":1711638651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.62.6_suppl_4.S18"}},"subtitle":["North American clinical experience"],"short-title":[],"issued":{"date-parts":[[2004,3,23]]},"references-count":21,"journal-issue":{"issue":"6_suppl_4","published-print":{"date-parts":[[2004,3,23]]}},"alternative-id":["10.1212\/WNL.62.6_suppl_4.S18"],"URL":"https:\/\/doi.org\/10.1212\/wnl.62.6_suppl_4.s18","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,23]]}}}